Metabolic Dysfunction Consistent With Premature Aging Results From Deletion of Pim Kinases

Rationale: The senescent cardiac phenotype is accompanied by changes in mitochondrial function and biogenesis causing impairment in energy provision. The relationship between myocardial senescence and Pim kinases deserves attention because Pim-1 kinase is cardioprotective, in part, by preservation of mitochondrial integrity. Study of the pathological effects resulting from genetic deletion of all Pim kinase family members could provide important insight about cardiac mitochondrial biology and the aging phenotype. Objective: To demonstrate that myocardial senescence is promoted by loss of Pim leading to premature aging and aberrant mitochondrial function. Methods and Results: Cardiac myocyte senescence was evident at 3 months in Pim triple knockout mice, where all 3 isoforms of Pim kinase family members are genetically deleted. Cellular hypertrophic remodeling and fetal gene program activation were followed by heart failure at 6 months in Pim triple knockout mice. Metabolic dysfunction is an underlying cause of cardiac senescence and instigates a decline in cardiac function. Altered mitochondrial morphology is evident consequential to Pim deletion together with decreased ATP levels and increased phosphorylated AMP-activated protein kinase, exposing an energy deficiency in Pim triple knockout mice. Expression of the genes encoding master regulators of mitochondrial biogenesis, PPAR&ggr; (peroxisome proliferator-activated receptor gamma) coactivator-1 &agr; and &bgr;, was diminished in Pim triple knockout hearts, as were downstream targets included in mitochondrial energy transduction, including fatty acid oxidation. Reversal of the dysregulated metabolic phenotype was observed by overexpressing c-Myc (Myc proto-oncogene protein), a downstream target of Pim kinases. Conclusions: Pim kinases prevent premature cardiac aging and maintain a healthy pool of functional mitochondria leading to efficient cellular energetics.

[1]  C. Bearzi,et al.  Activation of Cardiac Progenitor Cells Reverses the Failing Heart Senescent Phenotype and Prolongs Lifespan , 2008, Circulation research.

[2]  S. Houser,et al.  Pim-1 kinase antagonizes aspects of myocardial hypertrophy and compensation to pathological pressure overload , 2008, Proceedings of the National Academy of Sciences.

[3]  Z. Darżynkiewicz,et al.  Telomere shortening is an in vivo marker of myocyte replication and aging. , 2000, The American journal of pathology.

[4]  C. Zechner,et al.  Transcriptional coactivators PGC-1alpha and PGC-lbeta control overlapping programs required for perinatal maturation of the heart. , 2008, Genes & development.

[5]  N. Magnuson,et al.  Pim-1 Kinase-Dependent Phosphorylation of p21Cip1/WAF1 Regulates Its Stability and Cellular Localization in H1299 Cells , 2007, Molecular Cancer Research.

[6]  Torsten Doenst,et al.  PGC-1&bgr; Deficiency Accelerates the Transition to Heart Failure in Pressure Overload Hypertrophy , 2011, Circulation research.

[7]  D. Kelly,et al.  Transcriptional control of cardiac fuel metabolism and mitochondrial function. , 2011, Cold Spring Harbor symposia on quantitative biology.

[8]  Kathryn A. O’Donnell,et al.  Myc Stimulates Nuclearly Encoded Mitochondrial Genes and Mitochondrial Biogenesis , 2005, Molecular and Cellular Biology.

[9]  P. D. del Nido,et al.  Impaired Mitochondrial Biogenesis Precedes Heart Failure in Right Ventricular Hypertrophy in Congenital Heart Disease , 2011, Circulation. Heart failure.

[10]  Mark A Sussman,et al.  Pim-1 preserves mitochondrial morphology by inhibiting dynamin-related protein 1 translocation , 2013, Proceedings of the National Academy of Sciences.

[11]  Joshua M. Finkelstein,et al.  Metabolism and disease , 2012, Nature.

[12]  Mark A Sussman.  Mitochondrial integrity: preservation through Akt/Pim-1 kinase signaling in the cardiomyocyte , 2009, Expert review of cardiovascular therapy.

[13]  Mark A Sussman,et al.  Fibronectin contributes to pathological cardiac hypertrophy but not physiological growth , 2013, Basic Research in Cardiology.

[14]  Xiaoxue Zhang,et al.  Parkin Protein Deficiency Exacerbates Cardiac Injury and Reduces Survival following Myocardial Infarction*♦ , 2012, The Journal of Biological Chemistry.

[15]  Richard M. Cawthon,et al.  Telomere length measurement by a novel monochrome multiplex quantitative PCR method , 2009, Nucleic acids research.

[16]  E. Frohlich,et al.  The aging hypertensive heart: a brief update , 2008, Nature Clinical Practice Cardiovascular Medicine.

[17]  Yau-Huei Wei,et al.  Mitochondria and aging. , 2012, Advances in experimental medicine and biology.

[18]  A. Kraft,et al.  The Pim protein kinases regulate energy metabolism and cell growth , 2010, Proceedings of the National Academy of Sciences.

[19]  R. Scarpulla,et al.  Transcriptional regulatory circuits controlling mitochondrial biogenesis and function. , 2004, Genes & development.

[20]  Mark A Sussman,et al.  Fibronectin Is Essential for Reparative Cardiac Progenitor Cell Response After Myocardial Infarction , 2013, Circulation research.

[21]  Z. Wang,et al.  Pim kinase-dependent inhibition of c-Myc degradation , 2008, Oncogene.

[22]  T. Wenz.  Regulation of mitochondrial biogenesis and PGC-1α under cellular stress. , 2013, Mitochondrion.

[23]  P. Anversa,et al.  Myocyte mitotic division in the aging mammalian rat heart. , 1991, Circulation research.

[24]  J. Saffitz,et al.  Peroxisome proliferator-activated receptor gamma coactivator-1 promotes cardiac mitochondrial biogenesis. , 2000, The Journal of clinical investigation.

[25]  M. Matsuda,et al.  Aging-induced decrease in the PPAR-α level in hearts is improved by exercise training , 2002 .

[26]  Yibin Wang,et al.  Myc controls transcriptional regulation of cardiac metabolism and mitochondrial biogenesis in response to pathological stress in mice. , 2010, The Journal of clinical investigation.

[27]  Lauren E. Neidig,et al.  Increased Mitotic Rate Coincident with Transient Telomere Lengthening Resulting from Pim-1 Overexpression in Cardiac Progenitor Cells , 2012, Stem cells.

[28]  L. Chin,et al.  Telomere dysfunction induces metabolic and mitochondrial compromise , 2011, Nature.

[29]  J. Loscalzo,et al.  Cardiomyogenesis in the Aging and Failing Human Heart , 2012, Circulation.

[30]  Rick B. Vega,et al.  Perturbations in the gene regulatory pathways controlling mitochondrial energy production in the failing heart. , 2013, Biochimica et biophysica acta.

[31]  T. Tsuruo,et al.  Pim kinases promote cell cycle progression by phosphorylating and down-regulating p27Kip1 at the transcriptional and posttranscriptional levels. , 2008, Cancer research.

[32]  Jos Jonkers,et al.  Mice Deficient for All PIM Kinases Display Reduced Body Size and Impaired Responses to Hematopoietic Growth Factors , 2004, Molecular and Cellular Biology.

[33]  K. Noguchi,et al.  Physical and Functional Interactions between Pim-1 Kinase and Cdc25A Phosphatase , 1999, The Journal of Biological Chemistry.

[34]  Marcello Rota,et al.  Myocyte Turnover in the Aging Human Heart , 2010, Circulation research.

[35]  Mark A Sussman,et al.  Pim-1 Kinase Protects Mitochondrial Integrity in Cardiomyocytes , 2010, Circulation research.

[36]  Jiandie D. Lin,et al.  Transcriptional coactivator PGC-1 alpha controls the energy state and contractile function of cardiac muscle. , 2005, Cell metabolism.

[37]  D. Chan.  Fusion and fission: interlinked processes critical for mitochondrial health. , 2012, Annual review of genetics.

[38]  C. Thompson,et al.  The survival kinases Akt and Pim as potential pharmacological targets. , 2005, The Journal of clinical investigation.

[39]  Barbara Cannon,et al.  Ablation of PGC-1β Results in Defective Mitochondrial Activity, Thermogenesis, Hepatic Function, and Cardiac Performance , 2006, PLoS biology.

[40]  L. Marchionni,et al.  Effects of age and heart failure on human cardiac stem cell function. , 2011, The American journal of pathology.

[41]  S. Houser,et al.  Pim-1 regulates cardiomyocyte survival downstream of Akt , 2006, Nature Medicine.

[42]  G. Semenza,et al.  HIF-1 inhibits mitochondrial biogenesis and cellular respiration in VHL-deficient renal cell carcinoma by repression of C-MYC activity. , 2007, Cancer cell.

[43]  Mark A Sussman,et al.  Pim-1 kinase inhibits pathological injury by promoting cardioprotective signaling. , 2011, Journal of molecular and cellular cardiology.

[44]  Jun Ren,et al.  AMP‐activated protein kinase deficiency exacerbates aging‐induced myocardial contractile dysfunction , 2010, Aging cell.

[45]  D. Kelly,et al.  Transcriptional Activation Of Energy Metabolic Switches In The Developing And Hypertrophied Heart , 2002, Clinical and experimental pharmacology & physiology.

[46]  D. Kelly,et al.  Insulin-Resistant Heart Exhibits a Mitochondrial Biogenic Response Driven by the Peroxisome Proliferator-Activated Receptor-&agr;/PGC-1&agr; Gene Regulatory Pathway , 2007, Circulation.

[47]  S. Sihag,et al.  PGC-1alpha and ERRalpha target gene downregulation is a signature of the failing human heart. , 2009, Journal of molecular and cellular cardiology.

[48]  J. Callés-Escandon,et al.  Prolonged AMPK Activation Increases the Expression of Fatty Acid Transporters in Cardiac Myocytes and Perfused Hearts , 2006, Molecular and Cellular Biochemistry.

[49]  Manuel Serrano,et al.  The Hallmarks of Aging , 2013, Cell.

[50]  Mark A Sussman,et al.  Rejuvenation of Human Cardiac Progenitor Cells With Pim-1 Kinase , 2013, Circulation research.

[51]  M. Matsuda,et al.  Aging-induced decrease in the PPAR-alpha level in hearts is improved by exercise training. , 2002, American journal of physiology. Heart and circulatory physiology.